Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
RESMED INC
Next earnings ≈ Jul 31, 2026 · est. from filing cadence
Last earnings +0.9% on 2026-04-30
Revenue grew 9.8% YoY.
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
RESMED INC shows $5.15B in FY2025 revenue (+9.8% YoY), a 27.2% net margin, and 23.5% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro$19/mo · cancel anytime
Sources: SEC EDGAR (CIK 0000943819, latest 10-Q filed 2026-05-01) · EODHD · rules-based read · as of 6/17/2026, 7:27:37 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $3.20B | $3.58B | $4.22B | $4.69B | $5.15B |
| Gross profit | $1.84B | $2.02B | $2.36B | $2.66B | $3.05B |
| Operating income | $904M | $1.00B | $1.13B | $1.32B | $1.69B |
| Net income | $475M | $779M | $898M | $1.02B | $1.40B |
| Diluted EPS | $3.24 | $5.30 | $6.09 | $6.92 | $9.51 |
| Net margin | 14.8% | 21.8% | 21.3% | 21.8% | 27.2% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
58 tracked peers · median
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Last 90 days: 0 open-market buys · 5 sales
| 2026-06-08 | Farrell Michael J. Chairman and CEO | Exercise | 4.99K @ $146.34 | $730K |
| 2026-06-08 | Farrell Michael J. Chairman and CEO | Sell | 4.99K @ $193.96 | $968K |
| 2026-06-01 | Rider Michael J Global General Counsel | Tax | 268.74 @ $190.57 | $51.2K |
| 2026-05-07 | Farrell Michael J. Chairman and CEO | Exercise | 4.99K @ $146.34 | $730K |
| 2026-05-07 | Farrell Michael J. Chairman and CEO | Sell | 4.99K @ $207.82 | $1.04M |
| 2026-04-07 | Farrell Michael J. Chairman and CEO | Exercise | 4.99K @ $146.34 | $730K |
| 2026-04-07 | Farrell Michael J. Chairman and CEO | Sell | 4.99K @ $225.50 | $1.13M |
| 2026-04-01 | Sandercock Brett Chief Financial Officer | Sell | 1.00K @ $224.31 | $224K |
| 2026-04-01 | FARRELL PETER C Director | Sell | 2.00K @ $225.00 | $450K |
| 2026-03-09 | Farrell Michael J. Chairman and CEO | Exercise | 4.99K @ $146.34 | $730K |
| 2026-03-09 | Farrell Michael J. Chairman and CEO | Sell | 4.99K @ $251.03 | $1.25M |